Red cell genotyping and the future of pretransfusion testing
- 9 July 2009
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 114 (2) , 248-256
Abstract
Over the past 20 years the molecular bases of almost all the major blood group antigens have been determined. This research has enabled development of DNA-based methods for determining blood group genotype. The most notable application of these DNA-based methods has been for determining fetal blood group in pregnancies when the fetus is at risk for hemolytic disease of the fetus and newborn. The replacement of all conventional serologic methods for pretransfusion testing by molecular methods is not straightforward. For the majority of transfusion recipients matching beyond ABO and D type is unnecessary, and the minority of untransfused patients at risk of alloimmunization who would benefit from more extensively blood group–matched blood cannot be identified reliably. Even if a method to identify persons most likely to make alloantibodies were available, this would not of itself guarantee the provision of extensively phenotype-matched blood for these patients because this is determined by the size and racial composition of blood donations available for transfusion. However, routine use of DNA-based extended phenotyping to provide optimally matched donations for patients with preexisting antibodies or patients with a known predisposition to alloimmunization, such as those with sickle cell disease, is widely used.Keywords
This publication has 87 references indexed in Scilit:
- Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility studyBMJ, 2008
- Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell–mediated lysis of myelomaBlood, 2008
- The 1.3-Å resolution structure of Nitrosomonas europaea Rh50 and mechanistic implications for NH 3 transport by Rhesus family proteinsProceedings of the National Academy of Sciences, 2007
- Structure of the Nitrosomonas europaea Rh proteinProceedings of the National Academy of Sciences, 2007
- The Laminin 511/521–binding site on the Lutheran blood group glycoprotein is located at the flexible junction of Ig domains 2 and 3Blood, 2007
- Molecular basis of D variants in Chinese personsTransfusion, 2007
- Blood Group Antibodies and Their Significance in Transfusion MedicineTransfusion Medicine Reviews, 2007
- The DAU allele cluster of the RHDgeneBlood, 2002
- Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United KingdomBritish Journal of Haematology, 2001
- Alloimmunization in Sickle Cell Anemia and Transfusion of Racially Unmatched BloodNew England Journal of Medicine, 1990